However, these co-cultures studies were initiated in 2016, prior to the publication of work identifying ICAM-1/ EPCR dual binding as being associated with cerebral malaria [14], and had this information been available at the time we would have considered using one of the group B/A, dual-binding variants in our experiments. The gene discussed is ICAM1; the disease is cerebral malaria.